Recent Headlines
Within Biotechnology
Assay Designs Launches First Commercially Available EIA Kit for the Measurement of Circulating Hsp70
For over 15 years, Assay Designs has provided high quality antibodies, proteins, and kits for the precise quantification of key small and large molecule biomarkers in a variety of sample matrices and species. Since their merger with Stressgen® Bioreagents in 2005, the Assay Designs portfolio of products has included the full line of Stressgen brand kits and reagents, enabling researchers to investigate biological pathways involved in the cellular response to stress. - August 15, 2008 - Assay Designs
Biocore and AnaSpec Sign Distributor Agreement
AnaSpec and Biocore Pty Ltd today announced a non-exclusive distributor agreement that will allow Biocore Pty Ltd to distribute AnaSpec’s catalog and custom products throughout Australia. AnaSpec’s Director of Sales & Marketing, Violeta Rajkovska, noted, “AnaSpec is pleased... - August 14, 2008 - AnaSpec, EGT Group
AnaSpec Introduces GO Peptides™ - Research-Ready Peptides on Demand
AnaSpec is pleased to introduce GO Peptides™, the next evolution in peptide tools. - August 13, 2008 - AnaSpec, EGT Group
AnaSpec Introduces New SensoLyte™ 570 Generic MMP Assay Kit with Industry’s Highest Wavelength
Matrix metalloproteinases (MMPs) belong to a family of secreted or membrane-associated proteins capable of digesting extracellular matrix components. The importance of MMPs in tumor development and invasion as well as other diseases is well known. AnaSpec has introduced the SensoLyteTM 570 Generic... - August 09, 2008 - AnaSpec, EGT Group
RemedyMD Promotes Adam Slovik as President and Chief Operating Officer
RemedyMD® Inc., pioneer in the use of predictive informatics to help improve medical outcomes, today announced the promotion of Adam Slovik to President and Chief Operating Officer. “Adam has all the tools and talent to succeed in this role,” said Gary Kennedy, RemedyMD chairman... - August 06, 2008 - RemedyMD Inc.
Anavex Presents Neuroprotective Effects of Anavex 1-41 at the International Conference on Alzheimer's Disease 2008
Anavex Life Sciences presented its new findings of its ANAVEX 1-41 compound targeting Alzheimer's disease at ICAD (July 26 to 31, 2008). - August 02, 2008 - Anavex Life Sciences Corp.
CriticalPoint and Baxa Corp Introduce Crosswalk Tool for Sterile Compounding Regulatory Requirements
CriticalPoint, LLC , in partnership with Baxa Corporation, announces the availability of a free online reference tool for understanding state laws and regulations related to sterile compounding and USP 797 compliance. - July 30, 2008 - Baxa Corporation
Novus Biologicals and AnaSpec Sign Licensing Agreement for HiLyte™ Dyes
AnaSpec and Novus Biologicals today announced a licensing agreement that will allow Novus Biologicals to label Novus antibodies with AnaSpec HiLytePlus™ and HiLyte Fluor™ dyes. HiLytePlus™ and HiLyte Fluor™ are AnaSpec's proprietary series of high performance fluorescent... - July 30, 2008 - AnaSpec, EGT Group
Clinical Trials in Russia. 2nd Quarter 2008
On July 24, 2008 Synergy Research Group (SynRG), a Russia-based CRO, presented the current issue of its Orange Paper, a regular analysis of the clinical trial market in Russia. The report contains hundreds of figures as well as dozens of tables and pictures covering various aspects of the Russian... - July 26, 2008 - Synergy Research Group
AnaSpec Offers Custom Peptide-Aminoluciferin Synthesis
AnaSpec now offers custom synthesis service of peptide-aminoluciferin substrates. - July 23, 2008 - AnaSpec, EGT Group
Baxa Corporation Launches New Electronic Users’ Group Web Site
Baxa Corporation announces the launch of a new electronic users’ group Web site for health-system users of Baxa software and pharmacy automation equipment. This updated version of eBUG, or electronic Baxa Users’ Group provides an Internet community for sharing user experiences and best practices, as well as offering online technical support and tools for improving the user experience with Baxa products. - July 18, 2008 - Baxa Corporation
Colorado BioScience Association Launches New Pilot Externship Program, Connecting Jefferson County High School Science Teacher with Boulder's Array BioPharma
Colorado BioScience Association (CBSA) has announced the debut of a new educational program this summer – an externship for a local high school science teacher at one of the area’s prominent biotechnology companies. Tamra Miaja, a Bear Creek High School biology teacher is the first teacher to take part in CBSA’s pilot externship program and has spent part of her summer at Array BioPharma, headquartered in Boulder. - July 17, 2008 - Colorado BioScience Association
Korea's Largest Biotech Show Kicks Off in Osong
The 3rd BIO KOREA convention will be held from October 8th to 10th at Osong Bio-Technopolis. The event of this year offers a variety of high-level conference, international exhibition and partnership events and provide an opportunity to find business and technology partners. It expects to 350 companies and 25,000 visitors from all over the world. - July 17, 2008 - Bio Korea
Anavex Life Sciences Corp. Will Present New Findings at the International Conference on Alzheimer's Disease 2008 (July 26-31, 2008, Chicago, USA)
Anavex Life Sciences Corp. ("Anavex") (OTCBB: AVXL) announces its participation at the International Conference on Alzheimer's Disease 2008 (July 26-31, 2008, Chicago, USA), where it will present results obtained with Anavex 1-41 demonstrating a protective effect against the neurotoxicity... - July 15, 2008 - Anavex Life Sciences Corp.
Trevigen Announces the First Standardized Comet Assay Electrophoresis System (ES) for Direct Detection of DNA Damage
Trevigen, with funding from Phase 1 and Phase II SBIR grants, makes available a novel complete assay system which includes CometSlides™, reagents, control cells and an electrophoresis unit. - July 13, 2008 - Trevigen, Inc.
AnaSpec Introduces New Series of PAR Peptides
AnaSpec has introduced its latest series of PAR peptides. - July 09, 2008 - AnaSpec, EGT Group
New Anti-Keratin Antibodies Introduced by AnaSpec
AnaSpec has introduced two keratin antibodies that recognize both the intact and caspase digested N-terminal of K18 and K19 at Asp237. These antibodies are useful tools for studying keratin dynamics in mice undergoing hepatocyte apoptosis, patients with cirrhosis, and also in apoptotic cells of... - July 04, 2008 - AnaSpec, EGT Group
M-Scan Ltd Successfully Passes GMP Inspections by the FDA and UK MHRA
The world-leading provider of contract analytical services now conducts bio/pharmaceutical analysis to both GMP and GLP (compliant since 1992.) - July 04, 2008 - M-Scan
Colorado Confirmed as Top Bioscience State by National Rankings
It’s been a banner year for Colorado in the highly competitive state rankings arena. Genome Technology’s June publication ranks Colorado as one of the top 20 biotech locations in the world, and the Families USA Global Health Initiative Report ranked Colorado fourth among states that generated the most economic activity per dollar of funding from the NIH. Further, Colorado placed in the top five of all five categories in the Milken Institute’s State Technology and Science Index. - July 02, 2008 - Colorado BioScience Association
A Russian and Pakistani CRO Announce Alliance for Expansion of Global Clinical Trials Services
On June 30, 2008 Synergy Research Group (SynRG), a Russia-based CRO with more than 6-year experience in clinical trials in Russia announced the establishment of a new international CRO alliance with Metrics Research, a Pakistan-based CRO. This is the next step made by SynRG toward the formation of... - July 02, 2008 - Synergy Research Group
New SensoLyte HDAC Assay Kit Introduced by AnaSpec
Histone deacetylase (HDAC) enzymes modulate gene expression through the deacetylation of lysine residues on histone proteins and act as transcriptional repressors of genes. Based on their role in cell cycling, apoptosis and differentiation, HDACs have been chosen as therapeutic targets for the... - June 27, 2008 - AnaSpec, EGT Group
Trevigen Announces a Highly Sensitive, Fluorescent, One Hour PARP Inhibition Assay
Until now, commercially available PARP assay kits required multiple steps and were time consuming. Trevigen overcomes these drawbacks with the release of the HT Fluorescent Homogeneous PARP Inhibition Assay. - June 22, 2008 - Trevigen, Inc.
Xcelience Strengthens Development Services with Addition to Executive Team
The formulation development company’s services are led by an industry pioneer. - June 22, 2008 - Xcelience, LLC
Colorado’s Bioscience Community Celebrates the State’s Largest Medical Device Manufacturer
Gambro BCT, Inc., (to be CaridianBCT, Inc., as of July 14) is the largest medical device manufacturer headquartered in Colorado, with worldwide revenues approaching $500M and 2300 employees. The company had previously been a subsidiary of Gambro AB, a publicly traded, multinational healthcare company based in Sweden. The name CaridianBCT combines two words “care” and “meridian” to highlight the manufacturer's commitment to care and global reach. - June 20, 2008 - Colorado BioScience Association
AnaSpec Offers Custom Synthesis of Hydrocarbon-Stapled Peptides
The innovative technique of hydrocarbon stapling in peptides is introducing valuable new functionality to peptide-related research. AnaSpec is pleased to offer custom synthesis for hydrocarbon-stapled peptides. Hydrocarbon-stapled peptides are peptides capable of forming stable alpha helical... - June 20, 2008 - AnaSpec, EGT Group
Anavex Further Strengthens Board of Directors
Anavex Life Sciences Corp. ("Anavex") (OTCBB: AVXL) today announced the appointment of David L. Tousley, CPA, MBA, to its Board of Directors. Mr. Tousley is an accomplished professional with many years of experience as a senior financial and operations executive in start-up and... - June 20, 2008 - Anavex Life Sciences Corp.
New Anti-CARMA Antibody Series Released by AnaSpec
AnaSpec has introduced a new series of IHC validated antibodies, Anti-CARMA/CARD/Bimp antibodies. CARMA proteins are scaffold molecules that belong to the membrane-associated guanylate kinase-like (MAGUK) and the caspase-associated recruitment domain (CARD) protein families. They play critical... - June 19, 2008 - AnaSpec, EGT Group
AnaSpec Introduces Eleven New Peptides
This week AnaSpec, a world leader in custom and catalog peptides, introduced eleven (11) new peptides. - June 18, 2008 - AnaSpec, EGT Group
Device Surpasses Steroids in Strength and Overall Athletic Performance Enhancement
A new episode of Super Human Radio® reveals real-life results in world ranked athletes using a new nighttime technique for improving strength, stamina, physical and mental performance while providing deep, recuperative sleep. - June 15, 2008 - EarthPulse Tech, LLC
Baxa Corporation Launches PACT™ Product Line at the ASHP Summer Meeting
Baxa is promoting its new PACT (Productivity and Compliance Tools) product line at the American Society of Health-System Pharmacists 2008 Summer Meeting and Exhibition beginning today at the Washington State Convention and Trade Center in Seattle. The PACT line includes products and services designed to help pharmacies improve patient-care efficiencies and simplify compliance with state and federal regulations. - June 09, 2008 - Baxa Corporation
Trevigen Announces the Release of Four New Assay Kits for 3-D Cell Proliferation
Trevigen introduces four new 3-D cell proliferation kits, including a core kit and three different kits containing basement membrane extract, laminin I, and collagen I. These are the first standardized kits engineered for assessing the effects of compounds or genetic alteration on cell proliferation in 3-D culture. - June 07, 2008 - Trevigen, Inc.
Baxa Corporation Named Finalist for Third Year as a Best Company to Work For in Colorado
Englewood-based Baxa Corporation has been named a finalist in the 3rd Annual Best Companies to Work for in Colorado competition. This is the company’s third consecutive year as a finalist in the large company category. - June 05, 2008 - Baxa Corporation
Clinical Trials in Russia. 1st Quarter 2008
On June 2, 2008 Synergy Research Group (SynRG), a Russia-based CRO, presented the current issue of its Orange Paper, a regular analytical report on the market of clinical trials in Russia. According to the report The Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation (alias RosZdravNadzor, RZN) approved 130 new clinical trials in Russia in Q1 2008. - June 04, 2008 - Synergy Research Group
Baxa Launches New Microsite for STAR Center Training Facility
Baxa announces the launch of a new and improved microsite featuring enhanced course registration and an interactive tour of its STAR (Skills Training, Academics and Resources) Center training facility. Visitors to the new STAR Center interactive microsite can view instructor biographies, tour the entire facility online, register for current and future classes and download all course information. - June 02, 2008 - Baxa Corporation
Genomic Nanosystems Announced Today That It Has Received the Exclusive Patent Rights for Clonal Amplification and Digital PCR (Polymerase Chain Reaction) from Cytonix
Genomic Nanosystems, LLC has received the exclusive patent rights to U.S. patent No. 6,143,496. Patent ‘496 was first to describe methods for detecting single nucleic acid molecules after one amplification step, for amplifying one or more nucleic acids in nano-scale volumes or regions, and for carrying out digital PCR. - June 01, 2008 - Genomic Nanosystems
New SensoLyte™ 520 Cathepsin S Assay Kit Introduced by AnaSpec
AnaSpec has introduced the SensoLyte™ 520 Cathepsin S Assay Kit to its broad collection of long wavelength FRET protease assay kits. - May 29, 2008 - AnaSpec, EGT Group
AnaSpec Introduces Sixty New Peptides & 3 New Assay Kits
This week, AnaSpec introduced sixty (60) new catalog peptides and three (3) new assay kits. - May 27, 2008 - AnaSpec, EGT Group
Xcelience and Its CEO Are Finalists for Three Prestigious Business Awards
The Tampa-based CRO and its chief executive are voted as best company and CEO of the year. - May 26, 2008 - Xcelience, LLC
Colorado Governor Bill Ritter to Attend 2008 BIO Conference and Expo, Marketing The State’s Bioscience Sector to 20,000 Industry Executives
Colorado Governor Bill Ritter will attend BIO 2008 in San Diego, California, June 18, 2008, marketing the State’s bioscience sector to more than 20,000 bioscience company executives, researchers, economic development agencies and service providers attending the four-day event. A Colorado Pavilion (Booth #3049), on the trade show floor, will feature the state’s research institutions and highlight Colorado’s support for bioscience companies and its business-friendly environment. - May 24, 2008 - Colorado BioScience Association
AnaSpec Introduces 8 New Antibody Products
AnaSpec added eight (8) new antibody products to its growing collection. - May 24, 2008 - AnaSpec, EGT Group
Trevigen Releases the First Standardized 3-D Culture Cell Harvesting Kit
Trevigen releases the first standardized kit for isolating cells from 3-D Culture for biochemical analysis. The Cultrex® 3-D Culture Cell Haversting Kit is based on a nonenzymatic approach which prevents biochemical degradation during processing and overcomes the problems associated with extracting cells from BME or Laminin I in 3-D Culture. - May 24, 2008 - Trevigen, Inc.
Trace Contaminant Detection by Ultraviolet Microscopy and Microspectroscopy
Detection and analysis of trace organic and inorganic contaminants on precision devices by ultraviolet microscopy and microspectroscopy. - May 23, 2008 - CRAIC Technologies, Inc.
Anavex Announces Appointment of Oncology Specialist to Board of Directors, Changes to Executive Management
Anavex Life Sciences Corp. ("ANAVEX'') (OTC BB:AVXL.OB) today announced the appointment of Alison Ayers to its Board of Directors. Ms. Ayers is currently the Worldwide Commercial Head for Oncology at Pfizer, with responsibility for Pfizer's oncology portfolio, which includes more than 20 drug... - May 23, 2008 - Anavex Life Sciences Corp.
Baxa Web Site and Environmental Stewardship Programs Selected as Finalists for the Sixth Annual American Business Awards National Competition
Baxa Corporation announces its selection as a finalist in two categories for the 2008 American Business Awards. The company was chosen for Best Web Site and Best Corporate Environmental Responsibility Program. The American Business Awards recognize excellence at all levels of business – from management and sales to marketing and communications activities. Hailed as “the business world’s version of the Oscars,” The American Business Awards are the only national, all-encompassing awards program. - May 19, 2008 - Baxa Corporation
AnaSpec Introduces ClearPoint™ Heavy Isotope-Labeled Peptides
AnaSpec has introduced ClearPoint™ Peptides, heavy isotope-labeled peptides for absolute quantitation (AQUA) of proteins. - May 18, 2008 - AnaSpec, EGT Group
Baxa PadLock® Product Launch Wins Colorado BMA Best Strategy Distinction & Gold Key Campaign Award
Baxa Corporation has won two Colorado Business Marketing Association Awards for its integrated direct mail campaign featuring the PadLock® Set-Saver product – Best Strategy and Gold Key for Best B2B campaign (less than $50,000.) The campaign focused on the product’s features and benefits while providing a variety of different components for raising customer interest and awareness and promoting Baxa to this new market – IV nurses. - May 15, 2008 - Baxa Corporation
Lack of Sleep Affects Blood Sugar Insulin and Appetite Faster Than Previously Thought
Sleep polls around the world continue to indicate people of all ages are sleeping less well while Incidence of type 2 diabetes has reached epidemic proportions. For the first time in history, children are being diagnosed with adult onset diabetes. New research strongly suggests the mechanism causing poor sleep and how quickly poor sleep detrimentally affects appetite, blood sugar, insulin, and weight gain. - May 14, 2008 - EarthPulse Tech, LLC
Xcelience Launches New Service to Enhance Its Preformulation & Formulation Capabilities
The Tampa-based CRO continues its perpetual growth with new XRD support. - May 08, 2008 - Xcelience, LLC
Baxa Corporation Features PadLock®Set Saver at the Infusion Nurses Society Annual Meeting in Phoenix, AZ
Baxa is promoting its new PadLock Set Saver product at the Infusion Nurses Society 35th Anniversary Annual Meeting and Industrial Exhibition beginning today at the Phoenix Convention Center in Phoenix, Arizona. PadLock provides a secure seal for the end of the administration set, preventing contamination when the set is not being used for infusion. The Baxa sales team will demonstrate the new device at booth #420. - May 05, 2008 - Baxa Corporation
Colorado BioScience Association Announces Nine New Board Members
Nine new board members have been elected to the Colorado BioScience Association (CBSA) 40-member Board of Directors. In related action, seven existing members were elected to reappointments on the CBSA board this year. CBSA, with more than 400 members, is a not-for-profit corporation providing services and support for Colorado's growing biosciences industry. - May 04, 2008 - Colorado BioScience Association